We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.81B
AUM Growth
-$531M
Cap. Flow
-$1.24B
Cap. Flow %
-25.85%
Top 10 Hldgs %
18.16%
Holding
673
New
167
Increased
91
Reduced
97
Closed
256
Avg Time Held Equity + Options
0.6 quarters
Top 10 Avg Time Held Equity + Options
0.6 quarters
Top 20 Avg Time Held Equity + Options
0.4 quarters
Avg Time Held Equity only
0.6 quarters
Top 10 Avg Time Held Equity only
0.6 quarters
Top 20 Avg Time Held Equity only
0.4 quarters

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$59.4M
2
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$56.3M
3
SPG icon
Simon Property Group
SPG
+$52M
4
TSM icon
TSMC
TSM
+$45.4M
5
M icon
Macy's
M
+$44.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 29.53%
2 Real Estate 16.41%
3 Consumer Staples 12.46%
4 Financials 6.75%
5 Consumer Discretionary 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
XLU icon
351
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$24B
$14K ﹤0.01%
+400,000
New +$7.62M
2013 Q3
0 quarters
IP icon
352
PUT
International Paper
IP
$17B
$13K ﹤0.01%
21,416
-192,741
-90% -$8.58M
2013 Q2
1 quarter
HAL icon
353
PUT
Halliburton
HAL
$27.5B
$12K ﹤0.01%
20,000
-20,000
-50% -$937K
2013 Q2
1 quarter
XOP icon
354
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.19B
$10K ﹤0.01%
6,250
-33,925
-84% -$8.52M
2013 Q2
1 quarter
XRT icon
355
PUT
State Street SPDR S&P Retail ETF
XRT
$388M
$10K ﹤0.01%
+100,000
New +$4.03M
2013 Q3
0 quarters
TC icon
356
CALL
DELISTED
Thompson Creek Metals Company Inc. Ordinary Shares (Canada)
TC
$8K ﹤0.01%
+30,000
New +$101K
2013 Q3
0 quarters
KMB icon
357
CALL
Kimberly-Clark
KMB
$32.3B
$7K ﹤0.01%
26,075
-312,900
-92% -$29M
2013 Q2
1 quarter
BHI
358
PUT
DELISTED
Baker Hughes
BHI
$7K ﹤0.01%
+20,000
New +$964K
2013 Q3
0 quarters
NE icon
359
CALL
DELISTED
Noble Corporation
NE
$6K ﹤0.01%
28,600
-85,800
-75% -$2.92M
2013 Q2
1 quarter
DD icon
360
PUT
DELISTED
Du Pont De Nemours E I
DD
$5K ﹤0.01%
136,890
-234,608
-63% -$12.8M
2013 Q2
1 quarter
MDR
361
CALL
DELISTED
McDermott International
MDR
$2K ﹤0.01%
+6,667
New +$158K
2013 Q3
0 quarters
HPQ icon
362
CALL
HP
HPQ
$27B
$1K ﹤0.01%
+113,623
New +$1.25M
2013 Q3
0 quarters
A icon
363
Agilent Technologies
A
$48.1B
– –
-141,198
Closed -$4.32M –
ACN icon
364
PUT
Accenture
ACN
$130B
– –
-30,000
Closed -$243K –
AFG icon
365
American Financial Group
AFG
$11.8B
– –
-7,076
Closed -$346K –
AIG icon
366
American International
AIG
$40.5B
– –
-45,000
Closed -$2.01M –
AIV icon
367
Aimco
AIV
$256M
– –
-1,738,974
Closed -$6.96M –
AMGN icon
368
Amgen
AMGN
$225B
– –
-64,000
Closed -$6.31M –
AMZN icon
369
Amazon
AMZN
$2.83T
– –
-195,000
Closed -$2.71M –
ANF icon
370
Abercrombie & Fitch
ANF
$6.2B
– –
-10,429
Closed -$472K –
AXP icon
371
PUT
American Express
AXP
$209B
– –
-100,000
Closed -$182K –
BA icon
372
CALL
Boeing
BA
$151B
– –
-125,000
Closed -$2.6M –
BA icon
373
Boeing
BA
$151B
– –
-10,000
Closed -$1.02M –
BBDC icon
374
Barings BDC
BBDC
$888M
– –
-231,311
Closed -$6.36M –
BBWI icon
375
Bath & Body Works
BBWI
$3.48B
– –
-35,162
Closed -$1.61M –

Similar funds

UBS O'Connor's Q3 2013 Portfolio in Review

As of Q3 2013, UBS O'Connor held 673 positions worth $4.81B, down 9.9% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS O'Connor withdrew a net $1.24B in Q3 2013, closing 256 positions and reducing 97 holdings. Its most notable exit was Pfizer, an estimated $167M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 27% a quarter earlier, followed by Real Estate and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in Colgate-Palmolive worth $59.4M.

  • UBS O'Connor's largest Q3 2013 buy was Colgate-Palmolive: 1,002,498 shares worth $59.4M.
  • UBS O'Connor added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $56.3M increase.
  • UBS O'Connor's biggest Q3 2013 reduction was Advance Auto Parts, cutting an estimated $48.2M.
  • UBS O'Connor fully exited Pfizer in Q3 2013, selling an estimated $167M.
  • UBS O'Connor's ten largest holdings make up 18% of its $4.81B portfolio in Q3 2013.
  • UBS O'Connor opened 167 new positions and closed 256 in Q3 2013.
  • UBS O'Connor's portfolio value fell 9.9% quarter-over-quarter to $4.81B.

Based on UBS O'Connor's 13F filing for Q3 2013, filed 14 Nov 2013.